Vortex Medical develops a uniquely designed catheter-based system that facilitates en bloc removal of undesirable intravascular material such as pulmonary embolism. The company's innovative endomechanical device platform targets the endovascular market, enabling minimally invasive removal of clots and other intravascular obstructions. Vortex Medical has received SBIR funding from the Department of Health and Human Services and was previously involved with catheter-based mechanical thrombectomy technology developed with NIH support.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
Create Free Account
